ConductScience.org, home

Paper512896

Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.

Kreuter J and 2 others. J Pharm Sci, 1979. Cited by 65 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice. Papers, record 512896. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/512896

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Distribution and elimination of poly(methyl-2-14C-methacrylate) nanoparticle radioactivity after injection in rats and mice.
PubMed
Journal
J Pharm Sci
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
2.05
iCite
Revised in PubMed
2019-07-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kreuter JJ
2Täuber UU
3Illi VV

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethylmethacrylatesMajor topic
Animals
Feces
Female
Injections, Intramuscular
Injections, Intravenous
Kinetics
Lung
Male
Mice
Polymethacrylic Acids
Rats
Species Specificity
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
40667750Data-Driven Prediction of Nanoparticle Biodistribution from Physicochemical Descriptors.ACS Nano2025https://conductscience.org/library/papers/40667750PubMed
33542947From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier.Adv Ther (Weinh)2021https://conductscience.org/library/papers/33542947PubMed
30905577Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.Mol Ther2019https://conductscience.org/library/papers/30905577PubMed
26296985Ultrasound-Propelled Nanocups for Drug Delivery.Small2015https://conductscience.org/library/papers/26296985PubMed
25170183The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.Adv Drug Deliv Rev1995https://conductscience.org/library/papers/25170183PubMed
24978934Intrinsically radiolabeled nanoparticles: an emerging paradigm.Small2014https://conductscience.org/library/papers/24978934PubMed
22590683Nanotechnology and the treatment of HIV infection.Viruses2012https://conductscience.org/library/papers/22590683PubMed
16779701Nanotechnology: intelligent design to treat complex disease.Pharm Res2006https://conductscience.org/library/papers/16779701PubMed
11758771Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor models.Pharm Res2001https://conductscience.org/library/papers/11758771PubMed
10696512Determinants of passive drug entry into the central nervous system.Cell Mol Neurobiol2000https://conductscience.org/library/papers/10696512PubMed
8842044The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement.Pharm Res1996https://conductscience.org/library/papers/8842044PubMed
8726020Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/8726020PubMed
6524928Drug targeting by drug entrapment into ultrafine compartments as carriers.Appl Biochem Biotechnol1984https://conductscience.org/library/papers/6524928PubMed
1495900Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting.Pharm Res1992https://conductscience.org/library/papers/1495900PubMed
1488394Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats.Pharm Res1992https://conductscience.org/library/papers/1488394PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/512896

GET https://conductscience.org/api/papers/v1/512896/authors